Verus Capital Partners LLC reduced its position in shares of The Joint Corp. (NASDAQ:JYNT – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 130,914 shares of the company’s stock after selling 2,041 shares during the period. Verus Capital Partners LLC owned about 0.87% of Joint worth $1,392,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC raised its stake in Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after buying an additional 2,971 shares in the last quarter. Franklin Resources Inc. acquired a new stake in shares of Joint during the 3rd quarter worth about $175,000. Sanders Morris Harris LLC purchased a new stake in Joint during the fourth quarter worth approximately $228,000. BNP Paribas Financial Markets boosted its holdings in Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock valued at $258,000 after purchasing an additional 1,156 shares in the last quarter. Finally, Barclays PLC raised its holdings in Joint by 71.4% during the third quarter. Barclays PLC now owns 25,609 shares of the company’s stock worth $294,000 after purchasing an additional 10,671 shares in the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on JYNT. StockNews.com upgraded shares of Joint from a “hold” rating to a “buy” rating in a report on Friday, November 15th. Roth Mkm cut their target price on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, November 8th.
Joint Price Performance
JYNT stock opened at $11.41 on Friday. The company has a market cap of $170.98 million, a price-to-earnings ratio of -10.01 and a beta of 1.60. The company has a fifty day moving average price of $10.94 and a 200 day moving average price of $11.19. The Joint Corp. has a 12 month low of $9.10 and a 12 month high of $17.82.
Joint Company Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Further Reading
- Five stocks we like better than Joint
- What to Know About Investing in Penny Stocks
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Retail Stocks Investing, Explained
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to Profit From Value Investing
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNT – Free Report).
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.